Key facts
- Alpha-gal syndrome is a meat allergy triggered by bites from certain ticks, primarily the lone star tick.
- The condition causes an allergic reaction to alpha-gal sugar found in mammal meat.
- Symptoms include hives, diarrhea, and itchiness, often occurring hours after consuming meat or dairy.
- An estimated 450,000 Americans have developed the allergy.
- Diagnosis relies on blood tests, symptoms, and a history of tick bites.
- The FDA approved Xolair in 2024 to help manage severe allergic reactions to meat.
Health officials are increasing awareness of alpha-gal syndrome, a potentially life-threatening meat allergy triggered by bites from certain ticks, most notably the lone star tick. The condition, first identified about 15 years ago, is on the rise, with an estimated 450,000 Americans affected.
Alpha-gal syndrome is an immune response to a sugar molecule called alpha-gal, found in the meat of most mammals but not in humans. When certain ticks bite, they can introduce this sugar into the bloodstream, causing the immune system to develop antibodies that attack alpha-gal in subsequent meat or dairy consumption. Symptoms can include hives, diarrhea, dizziness, and difficulty breathing, often appearing hours after eating red meat or dairy products.
Experts attribute the increase in diagnoses to greater awareness among healthcare professionals and the public, as well as the expanding geographic range of the lone star tick. Diagnosis typically involves a blood test to detect alpha-gal antibodies, alongside a review of symptoms and any recalled tick bites.
Patients are generally advised to avoid beef, pork, lamb, and other mammalian meats. Some individuals can tolerate dairy products, while others with severe reactions may need to avoid animal byproducts like gelatin. A rare exception is meat from genetically modified 'GalSafe' pigs, approved by the FDA in 2020.
The allergy can sometimes resolve on its own over several years, but avoiding further tick bites is critical. In 2024, the FDA approved Xolair, an injectable drug that helps reduce the severity of allergic reactions following accidental exposure to meat, though it does not reverse the condition. Researchers are also investigating other existing drugs that might interfere with the allergic signaling process.